Board of Advisors

Carlos Cuevas is the associate vice chancellor for health policy and strategy at the State University of New York (SUNY). In this role, Carlos leads the Health Policy and Research Team within the Office of Academic Health and Hospital Affairs. His work supports the strategic direction, financing, operations and mission of SUNY’s four academic medical centers. Prior to joining SUNY, Carlos worked at SOMOS (2017–2023) and ultimately served as the organization’s chief strategy officer. SOMOS is a network of over 2,500 diverse, community-based providers that deliver care to predominantly low-income and minority communities in New York City. During his tenure at SOMOS, Carlos helped the organization become the first health care entity in New York State to implement full-risk/capitated value-based contracts for both the Medicaid and Medicare populations. Carlos also served as the senior policy advisor to the New York state Medicaid director from 2013–2017. In that time, Carlos oversaw the planning and financing of various health care initiatives pertaining to New York State’s $70 billion Medicaid program. For his efforts in helping underserved populations gain access to health care, Carlos was named Health Policy Leader of the Year (2015) by the Association of Hispanic Healthcare Executives and was selected as part of Crain’s 40 Under 40 Business Leaders in New York City (2019). A native New Yorker, Carlos earned a BA from Columbia University, an MPA from the Columbia University School of International and Public Affairs (SIPA), and an MPH from Columbia University Mailman School of Public Health.

Jean Drouin, MD, is the founder and CEO of Clarify Health Solutions, which enables health systems, payers, and life sciences organizations to deliver more satisfying and efficient care through advanced analytics, machine learning, and digital care optimization solutions. Prior to Clarify, Jean was a Senior Partner at McKinsey & Company, where his roles included leading the global Healthcare IT and Digital Practice, setting up the UK and Australian Healthcare Practices, and serving as the founding Head of McKinsey Advanced Healthcare Analytics (MAHA). He also served as Head of Strategy for NHS London, which oversaw London’s $15 billion hospital and primary care system. In these roles, he served over 20 countries and 100 health systems and payers on engagements that generated over $1 billion in efficiency and quality improvements. Jean is passionate about transforming health care delivery across the continuum of care. He has written and spoken extensively on value-based care, population health, new payment models, and the role of big data and analytics in delivering better outcomes. Jean holds MD and MBA degrees from Stanford and an AB in Molecular Biology from Princeton. He is the former vice-chair of Lester B. Pearson United World College of the Pacific.

Elizabeth Duggal is the Principal of Duggal Advisory, a consulting firm that focuses on an array of strategic, fundraising, and operational initiatives for business leaders and nonprofits. 

Until 2022, she served as the chief operating officer at the Solomon R. Guggenheim Museum and Foundation. 

Ms. Duggal came to the Guggenheim from an 18-year career with the Smithsonian, holding a number of senior positions within the Institution including the Hirshhorn Museum and Sculpture Garden, National Museum of Natural History, National Museum of the American Indian, and International Museum Professional Education Programs.

She began her nonprofit career at the British Museum starting as the inaugural chair of the American Friends of the British Museum in the UK. Previously, she worked in London at Salomon Brothers, Fidelity Investment Services, and American Express Europe.

Ms. Duggal was chair of the board of directors of Goldbug, Inc. Privately held, Goldbug is one of the largest distributors of infant and children’s apparel and accessories in the US.

Active in community affairs, she is currently the chair of Meridian International’s Center for Cultural Diplomacy and a member of the Strategic Planning Committee for the International Council of Museums.  Ms. Duggal also serves on the Board of Advisors at Columbia University Mailman School of Public Health and the honorary board of the Halcyon Organization. She is a trustee of Turquoise Mountain (US) and the Jordan River Foundation (US) and is also trustee emeritus of Children’s National Medical Center in Washington, DC.

Ms. Duggal earned an MBA from the Wharton School at the University of Pennsylvania and a BA in International Relations from Tufts University.

Dr. Xue Fang is currently a member of the President’s Advisory Council and a member of the Graduate School Dean’s Leadership Council of Princeton University. She also serves as a director in Teach for China, Inc. Born in Beijing, China, Xue studied Biology at Beijing University before attending the Graduate School of Princeton University in 1988 to study Neuroscience. She received a PhD in Neuroscience and Psychology in 1995 from Princeton University and an MS in Biostatistics from Columbia University Mailman School of Public Health in 1998. She has participated in medical research projects and has worked as a biostatistician in Schering-Plough, a pharmaceutical company in New Jersey. Xue has a special interest in education and enjoys reading extensively.

(Ex-Officio Member): Linda P. Fried, MD, MPH, is Dean and DeLamar Professor of Public Health at the Columbia Mailman School, professor of Medicine at Columbia’s College of Physicians & Surgeons, and senior vice president at Columbia University Medical Center. Dr. Fried is a geriatrician, epidemiologist, and internationally renowned scientist who has propelled our understanding of how to create healthy aging and set the basis for a transition to an aging world that benefits all ages. She has led the scientific work to define the medical syndrome of frailty and its causes and prevention as keys to optimizing health and is the codesigner and founder of Experience Corps. Prior to becoming dean in 2008, Dr. Fried served as director of the Division of Geriatric Medicine and Gerontology and of the Center on Aging and Health at Johns Hopkins University. Dr. Fried is also the recipient of numerous awards including the French National INSERM International Prize in Medical Research and was named a “Living Legend in Medicine” by the U.S. Congress. She is an elected member of the National Academy of Medicine and past president of the Association of American Physicians. Dr. Fried was named, in 2014, one of the most influential scientific minds of the past decade by Thompson Reuters, and the New York Times has called her one of the 15 world leaders in science. 

Peter Grubstein has deep operating and investing experience in manufacturing and in the environmental sectors. He is the founder and Managing Member of N*GEN, a venture capital and growth equity investment firm investing in healthy and sustainable living. He has been investing in sustainable businesses with innovative solutions to impact the world’s biggest problems. Mr. Grubstein has 40 years of experience as an entrepreneur, operating executive, and venture capital investor and has grown N*GEN from one of the earliest to invest in sustainable technologies. Prior to founding N*GEN, Mr. Grubstein made diverse private investments ranging from leveraged buyouts and leveraged recapitalizations to early venture investments in materials science enterprises.

Earlier in his career, he was CEO of American Tanning, a manufacturing business owned by his family, from 1982 to 1983. Subsequently, at KD/P Equities, J.B. Poindexter & Co., and Grubstein Holdings, Ltd., he worked on investments such as Carolina Steel Corporation and focused on supply chain and logistics efficiencies to drive profitability, including selecting acquisitions to improve overall operations for businesses that reach a certain scale.

Mr. Grubstein is currently a member of the Board of Directors of the Ripley Conservancy and of Enzymedica, a provider of digestive enzyme supplements. Mr. Grubstein is a graduate of Yale University.  At the Board level, he has served on Governance, Sustainability, Audit and Compensation committees over a 40 year period and a number of different business cycles.

Abby Levy is Managing Partner and Co-Founder of Primetime Partners, an early-stage venture capital fund focused on improving the quality of living of older adults. Abby has spent her career helping businesses and consumer brands grow as an operator, entrepreneur and advisor, most notably in the wellness sector. Prior to Primetime Partners, Abby was a senior executive at SoulCycle, where she oversaw business development and new digital products. Abby has also been a Founder herself, teaming with Arianna Huffington as the Founding President of Thrive Global, a behavior change technology company focused on employee productivity and wellness. Abby began her career at McKinsey & Company then led product development at OXO International. She is a graduate of Princeton University and Harvard Business School.

Josh Mailman is an active investor in the most game-changing for-profit and nonprofit enterprises he can find. He believes we must assist in advancing a reimagining of how finance can advance positive societal change. Currently, Mr. Mailman is Managing Director of Serious Change L.P., a $70 million impact investment vehicle started in 2006. Serious Change invests in early-stage companies committed to environmental sustainability, diversity, advancing social justice, and meeting human needs. He also founded Social Venture Network with Wayne Silby of Calvert Group in 1987 as well as the Threshold Foundation (1981) and Business for Social Responsibility (1992). Mr. Mailman’s other nonprofit board activities include Echoing Green, the Fund for Global Human Rights, and the Calvert Foundation.

As senior vice president of innovation at the Partnership for NYC, Stacey Matlen partners with New York governmental agencies to understand their challenges and recruits innovative solutions to solve these challenges. Of note, she oversees three programs with missions to make New York the global leader in transportation, water, and buildings: the Transit Tech Lab, Environmental Tech Lab, and Buildings Tech Lab, respectively. Through the Transit Tech Lab, Stacey works with the four of the largest transit agencies in North America to make their systems more accessible, responsive, efficient, and resilient. Through the Environmental Tech Lab, launched in May 2023, in partnership with New York City Department of Environmental Protection, Stacey works to enable the largest municipal water/wastewater utility in the country to source, pilot, and evaluate new technologies to better prepare and respond to the impacts of climate change. In July 2024, Stacey led the launch of the Buildings Tech Lab, a public-private innovation lab to help New York City Department of Buildings quickly identify and test new technologies to help the largest building regulator in the country keep construction costs and times low, while prioritizing building safety and sustainability across the 1.1 million New York City buildings.

Stacey has a public sector, startup, and public health background: She led multiple initiatives with the City of Detroit’s Office of Mobility Innovation and founded an award-winning startup that increased healthy food access for low-income residents. Stacey holds a master’s in public health and a bachelor’s degree with high distinction from the University of Michigan.

Stacey has been recognized by Crain’s New York 40 under 40, City & State New York Power Transportation 100, and Crain’s Detroit 20 in their 20s.

Lila Preston is a partner at Generation Investment Management, a global investment management firm focused on long-term sustainable investing (www.generationim.com), where she joined in 2004. At Generation, she coheads the firm’s growth equity strategy, helping to scale sustainable solutions businesses. Prior to joining Generation, Lila was a director of finance and development at VolunteerMatch in San Francisco, and also a consultant for clients such as Save the Children (YouthNoise). Prior to joining VolunteerMatch, she was a Fulbright Fellow in Southern Chile, where she worked on community-based forestry and conservation projects. Lila graduated with honors from Stanford University with a BA in English and Latin American Studies. She also received an MBA from the London Business School. Lila is also a World Economic Forum Young Global Leader. Lila speaks fluent Spanish. Lila serves as a Board Director for CiBO Technologies, Recyclebank, and Seventh Generation’s Social Mission Board, as well as Board Observer for Optoro and Toast.

Carlos E. Sanchez, MD, is the director of pediatric skull base surgery at Children’s National Hospital and a principal investigator in the Center for Cancer and Immunology Research at George Washington University. As a neurosurgeon-scientist, Dr. Sanchez has dedicated his career to improving the health of children and adults with brain tumors. He is a consultant for the Cellular Tissue and Gene Therapies Advisory Committee of the FDA. Dr. Sanchez serves as a CEO for Insurgiac Corporation, a health tech company focusing on bridging the health equity gap between academic medical centers and community hospitals. He was nominated as a cross-disciplinary fellow at Harvard Business School by Clayton Christensen, completed his postdoctoral fellowship at the Massachusetts General Hospital, and completed his neurosurgical training at UCSD and the University of New Mexico. Dr. Sanchez is married to Christina Rosenberger and lives in Bethesda, MD with their three children.

Rajiv Singh is an investor and strategic advisor in the food and agribusiness sector, serving corporations, funds, entrepreneurs, and professionals with a focus on innovation, value creation, and corporate finance. He serves as the cochairperson for FoodShot Global, a moonshot-style challenge program he helped found, designed to address key problems in the food sector to make it more healthy, sustainable, and equitable. He formerly served as CEO of Rabobank North America, where he established deep relationships with leaders, owners, and management at companies in the food, agribusiness, commodities, and energy sectors, collaborating with them in investments, financing, capital markets, and corporate transformation transactions. As CEO, Rajiv was responsible for corporate banking, private equity and venture capital, mergers and acquisitions, specialized products, food and agribusiness research, and capital markets activities, as well as all operational and support functions. He launched a number of innovation platforms while at the bank, focused on addressing challenges in the food sector. He has been the chair or member of principal risk committees focused on equity, credit, compliance, and reputation. As a special focus on food sector innovation, he led the launch of platforms like Foodbytes and MIT Food Prize (pitch competitions in the food and agribusiness sectors), and Terra (a science and technology–focused accelerator program for food/ag entrepreneurs with large corporates as sector partners). Prior to Rabobank, Rajiv had a career in investment banking and special situations investing at Deutsche Bank and Credit Suisse and in corporate strategy and project operations at United Technologies and Nestle, Rajiv is a graduate of the Indian Institute of Technology and Harvard Business School.

Ian Woo is a managing director at C-Bridge Capital, a health care–dedicated private equity firm focused on growth and late-stage investment opportunities with $1.7 billion under management. Ian is also the president and CFO of Everest Medicines, a biopharma platform started by C-Bridge Capital that is focused on bringing innovative medicines to Greater China and Asia emerging markets across four therapeutic areas: oncology, infectious disease, renal & immunology, and CNS. Previously, Ian was a managing director in the global health care group at Lazard, one of the world's premier financial advisory and asset management firms. He worked with numerous global biopharma companies and led Lazard’s healthcare efforts in Greater China. Ian joined Lazard in 2005 and was based in New York, other than from 2012 to 2016, when he worked in the firm’s Hong Kong office. Ian holds a Master of Business Administration from Columbia Business School, a master’s degree in molecular and cellular biology from Columbia University Graduate School of Arts & Sciences, and a bachelor’s degree in biology from Tufts University. Ian was also a student at Harvard University Graduate School of Arts & Sciences and conducted research at Harvard Medical School and Brigham and Women’s Hospital, where he was an author on multiple published papers.

Dr. John Rowe is Julius B. Richmond Professor of Health Policy and Aging in the Department of Health Policy and Management at the Columbia University Mailman School of Public Health. Previously he served as chairman and CEO of Aetna, Inc., president and chief executive officer of Mount Sinai NYU Health, the Mount Sinai Hospital, and the Mount Sinai School of Medicine in New York City. Before joining Mount Sinai, Dr. Rowe was a professor of medicine and the founding director of the Division on Aging at Harvard Medical School. He led the MacArthur Foundation Research Network on Successful Aging and currently leads the Foundation’s Network on An Aging Society. Dr. Rowe is a fellow of the American Academy of Arts and Sciences and a member of the Institute of Medicine of the National Academy of Sciences. He serves on the Board of Trustees of the Rockefeller Foundation.

Charles M. Diker is the managing partner of Diker Management LLC, founded in 2002, where he is a registered investment advisor managing various small and micro-cap funds. He is the chairman of the board of Cantel Medical Corp., an NYSE-listed company that markets and manufactures infection control products, and a director of the Loews Corporation. Currently, Mr. Diker is the founding chairman of the National Museum of the American Indian–New York and the George Gustav Heye Center, and is a trustee of New York Public Radio, Poly Prep Country Day School, and the Solomon R. Guggenheim Museum. He is the former president of the American Friends of the Israel Museum. After graduating with honors from Harvard College, Mr. Diker received his MBA from Harvard Business School. He and his wife, Valerie, reside in Manhattan.

South African Adrian Gore is the founder and chief executive officer of Discovery, a multinational financial services group. Discovery is a global thought leader in consumer-driven insurance and the integration of behavioral change with health and life and short-term insurance. It serves over six million customers worldwide. Mr. Gore chairs the South African chapter of Endeavor, a global nonprofit organization that identifies and assists high-growth entrepreneurs. He sits on the World Economic Forum Global Health Advisory Board, which is committed to improving global health care; the Brookings Advisory Board; and the Massachusetts General Hospital Global Health Advisory Board. Mr. Gore graduated from Wits University in 1986.

Frank R. Jimenez is general counsel and corporate secretary at GE HealthCare, a Nasdaq 100 medical technology, pharmaceutical diagnostics, and digital solutions company. Previously, Mr. Jimenez served as vice president, general counsel, and corporate secretary of Raytheon Company, a defense contractor, and, following Raytheon’s merger with United Technologies Corporation, as executive vice president and general counsel of Raytheon Technologies Corporation, an aerospace and defense company. In prior public company positions, Mr. Jimenez served as general counsel of Bunge Limited (agribusiness and food), ITT Corporation (defense technology and industrial products), and ITT spin-off Xylem Inc. (fluid technologies). In prior public service positions, Mr. Jimenez served as general counsel of the U.S. Navy, deputy general counsel of the U.S. Department of Defense, principal deputy general counsel of the Navy, chief of staff at the U.S. Department of Housing and Urban Development, and deputy chief of staff and acting general counsel for former Florida Governor Jeb Bush. He was previously a litigation partner at Steel Hector & Davis LLP (now Squire Patton Boggs LLP). Mr. Jimenez serves on the boards of Navy shipbuilder Huntington Ingalls Industries, the Ann & Robert H. Lurie Children’s Hospital of Chicago, and Equal Justice Works, where he serves as chairman. He also serves on the advisory boards of Columbia University Mailman School of Public Health and the Yale Law School Center for the Study of Corporate Law, as well as on the University of Miami President’s Council.

Martin Oppenheimer practiced law for more than 50 years at the Proskauer firm. He specialized in labor and employment law representing Fortune 500 companies, served as chair of the labor and employment department of the firm and lectured and wrote extensively in his field. Most of his time is now spent in the not-for-profit arena, including serving as Board Member of the 92nd Street YMHA, the N.Y. Road Runners, and the Emelin Theatre, and as emeritus chairman of City Center of Music and Drama and director emeritus of Lincoln Center for the Performing Arts. Mr. Oppenheimer graduated from Yale Law School and attended Goethe University in Germany as a Fulbright Scholar.

Perri Peltz is a documentary filmmaker, journalist, and public health advocate who most recently directed the HBO documentary Warning: This Drug May Kill You, about the opioid addiction epidemic. She also coproduced and codirected the HBO documentary Risky Drinking, a no-holds-barred look at alcohol use. She codirected “A Conversation About Growing Up Black” as part of the “Conversation on Race” series for The New York Times op-docs. Other films include HBO’s Remembering the Artist: Robert De Niro, Sr., The Education of Dee Dee Ricks, Prison Dogs, and A Journey of a Thousand Miles: Peacekeepers. Perri hosts The Perri Peltz Show and Doctor Radio Reports  for the SiriusXM satellite network. Before working in documentary films, Perri was an award-winning broadcast journalist for NBC, ABC, and CNN. She is currently a doctoral candidate at Columbia University Mailman School of Public Health and attended Brown University.

E. Eric Tokat is a partner and a founding member of the Healthcare Practice at Centerview Partners, a leading independent investment banking firm specializing in general advisory, mergers and acquisitions, divestitures, and principal investing, with offices in New York, London, San Francisco, and Los Angeles. Mr. Tokat has advised numerous clients on a broad range of strategic advisory assignments and transactions exceeding $200 billion in value across developed and emerging markets. He serves on the Board of the International Rescue Committee (IRC) and is a member of the Global Leadership Council at The Brookings Institution. Mr. Tokat is also a vice chair of the Child Health Initiative under the Office of the UN Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals. Mr. Tokat received his BA from Bogazici University and MA from Columbia.

Betsy Williams is the founder and cochair of Emerging Public Leaders (EPL), which is building a new generation of civil service leaders in Africa to help accelerate Africa’s development and economic growth. EPL builds on the success of the President’s Young Professionals Program in Liberia, which Ms. Williams founded while working with then–Minister of Health Dr. Walter Winkle, seeing the country’s urgent need for a stronger civil service following two civil wars, and recognizing the potential of youth to drive that progress. Ms. Williams’ work has focused on the intersection of social development, foreign policy, and global health, having launched and supported innovative programs at USAID, JSI, Asia Society, and Physicians for Human Rights. She graduated cum laude from Princeton University and received her MPH from the Columbia University Mailman School of Public Health, where she currently serves on the Board of Advisors. She is married to Tom Moore and lives in Washington, DC, with their two daughters.